Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Thromboxane receptor antagonists in AERD/asthma

Thromboxane receptor antagonists in AERD/asthma

US Patent 11571412 · Granted Feb 7, 2023

Estimated economic value: $535,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods of treating cardiac fibrosis with ifetroban2024
Injectable ibuprofen formulation2023
Compositions and methods of treating cardiac fibrosis with ifetroban2021
Compositions and methods of treating cardiac fibrosis with ifetroban2020
Compositions and methods of treating muscular dystrophy with thromboxane-A2 rece2019
Compositions and methods of treating cardiac fibrosis with ifetroban2019
Compositions and methods of treating muscular dystrophy with thromboxane-A2 rece2018
Compositions and methods of treating cardiac fibrosis with ifetroban2018
Treating critically ill patients with intravenous ibuprofen2018
Stabilized statin formulations2017
Compositions and methods of treating cardiac fibrosis with ifetroban2017
Treating critically ill patients with intravenous ibuprofen2017